» Articles » PMID: 34815397

G-protein-coupled Receptor P2Y10 Facilitates Chemokine-induced CD4 T Cell Migration Through Autocrine/paracrine Mediators

Overview
Journal Nat Commun
Specialty Biology
Date 2021 Nov 24
PMID 34815397
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

G-protein-coupled receptors (GPCRs), especially chemokine receptors, play a central role in the regulation of T cell migration. Various GPCRs are upregulated in activated CD4 T cells, including P2Y10, a putative lysophospholipid receptor that is officially still considered an orphan GPCR, i.e., a receptor with unknown endogenous ligand. Here we show that in mice lacking P2Y10 in the CD4 T cell compartment, the severity of experimental autoimmune encephalomyelitis and cutaneous contact hypersensitivity is reduced. P2Y10-deficient CD4 T cells show normal activation, proliferation and differentiation, but reduced chemokine-induced migration, polarization, and RhoA activation upon in vitro stimulation. Mechanistically, CD4 T cells release the putative P2Y10 ligands lysophosphatidylserine and ATP upon chemokine exposure, and these mediators induce P2Y10-dependent RhoA activation in an autocrine/paracrine fashion. ATP degradation impairs RhoA activation and migration in control CD4 T cells, but not in P2Y10-deficient CD4 T cells. Importantly, the P2Y10 pathway appears to be conserved in human T cells. Taken together, P2Y10 mediates RhoA activation in CD4 T cells in response to auto-/paracrine-acting mediators such as LysoPS and ATP, thereby facilitating chemokine-induced migration and, consecutively, T cell-mediated diseases.

Citing Articles

Combination adjuvant improves influenza virus immunity by downregulation of immune homeostasis genes in lymphocytes.

Dollinger E, Hernandez-Davies J, Felgner J, Jain A, Hwang M, Strahsburger E Immunohorizons. 2025; 9(2).

PMID: 39849993 PMC: 11841980. DOI: 10.1093/immhor/vlae007.


Ganglion cell-derived LysoPS induces retinal neovascularisation by activating the microglial GPR34-PI3K-AKT-NINJ1 axis.

Chen L, Zhang H, Zhang Y, Li X, Wang M, Shen Y J Neuroinflammation. 2024; 21(1):278.

PMID: 39468551 PMC: 11520652. DOI: 10.1186/s12974-024-03265-7.


GPCRs: emerging targets for novel T cell immune checkpoint therapy.

Dickinson K, Yee E, Vigil I, Schulick R, Zhu Y Cancer Immunol Immunother. 2024; 73(12):253.

PMID: 39358616 PMC: 11447192. DOI: 10.1007/s00262-024-03801-7.


Temporal Dynamics of Purinergic Receptor Expression in the Lungs of Marek's Disease (MD) Virus-Infected Chickens Resistant or Susceptible to MD.

Akbar H, Jarosinski K Viruses. 2024; 16(7).

PMID: 39066292 PMC: 11281646. DOI: 10.3390/v16071130.


ATP release mediated by pannexin-3 is required for plasma cell survival via P2X4 receptors in bone marrow.

Paz-Lopez S Purinergic Signal. 2024; .

PMID: 38772961 DOI: 10.1007/s11302-024-10024-z.


References
1.
Forster R, Davalos-Misslitz A, Rot A . CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol. 2008; 8(5):362-71. DOI: 10.1038/nri2297. View

2.
Cyster J, Schwab S . Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu Rev Immunol. 2011; 30:69-94. DOI: 10.1146/annurev-immunol-020711-075011. View

3.
Kalinski P . Regulation of immune responses by prostaglandin E2. J Immunol. 2011; 188(1):21-8. PMC: 3249979. DOI: 10.4049/jimmunol.1101029. View

4.
Ricciotti E, FitzGerald G . Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011; 31(5):986-1000. PMC: 3081099. DOI: 10.1161/ATVBAHA.110.207449. View

5.
Regard J, Sato I, Coughlin S . Anatomical profiling of G protein-coupled receptor expression. Cell. 2008; 135(3):561-71. PMC: 2590943. DOI: 10.1016/j.cell.2008.08.040. View